Lucid Diagnostics (LUCD) Cost of Revenue (2020 - 2026)

Lucid Diagnostics has reported Cost of Revenue for 7 years, with the latest figure at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 4.77% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (down 80.18% YoY), and the FY2025 full-year result was $6.7 million, down 59.48% from the prior year.
• Cost of Revenue for Q1 2026 stood at $1.6 million, up from -$5.7 million in the prior quarter.
• The five-year high for Cost of Revenue was $11.9 million in Q4 2023, with the low at -$5.7 million in Q4 2025.
• Historically, Cost of Revenue has averaged $3.5 million across 5 years, with a median of $3.9 million in 2022.
• Annual changes were most pronounced in 2022 — Cost of Revenue soared 1029.17% — and 2025, when it tumbled 149.5%.
• Lucid Diagnostics' Cost of Revenue stood at $5.0 million in 2022, then soared by 137.02% to $11.9 million in 2023, then dropped by 3.14% to $11.5 million in 2024, then slumped by 149.5% to -$5.7 million in 2025, then jumped by 128.52% to $1.6 million in 2026.
• The last three Cost of Revenue figures came in at $1.6 million (Q1 2026), -$5.7 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.